IDT

IDT AUST FPO [IDT]
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States. The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
Healthcare · ASX Small Cap
$0.0460 -2.1%

Updated 3 Sep 2026 · Signals refresh every scan

Appeared in 2 consecutive scansFirst seen: 2026-02-25
Get alerts when IDT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IDT — Free

Active Signals

Bullish Signals

  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Drifting lower — down 8.0% over the last 5 days
  • Trading above the 200-day average — the long-term trend is on your side
  • Cash positive / operating cashflow positive
  • Low P/S ratio (1.0x)
  • Moderate revenue growth (+15%)
  • EPS estimates revised upward (+10pts)
  • Small-cap ($20-100M)
  • CANSLIM I: Institutional ownership (18%)
  • Sentiment is mixed — no strong consensus either way
  • Altman Z-Score distress zone (1.78 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.047)
  • RBA hiking (-3pts)

Risk Signals

  • Negative profit margins (-13%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about IDT
"What's driving IDT today?" "How does IDT compare to peers?" "Key risks for IDT?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification regarding unquoted securities - IDT
NONE Application for quotation of securities - IDT
NONE Change of Director's Interest Notice - GS
Announcement tone +3pts

Recent ASX Announcements

2026-09-02 Notification regarding unquoted securities - IDT
2026-09-02 Application for quotation of securities - IDT
2026-08-24 Change of Director's Interest Notice - GS
2026-08-20 FY26 Full Year Results Presentation
2026-08-20 FY26 Full Year Results

Key Metrics

$20.1M
Market Cap
228K
Avg Volume
0.9x
Vol Ratio
$0.03 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-13.3%
ROE
-13.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 72%
LLeader vs LaggardpassRS: 18
IInstitutional SponsorshippassInst: 18%
MMarket DirectionneutralNeutral

Sector: Healthcare

113 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
REG -27.0%CAN +25.0%BIT -20.0%MEM +20.0%CMP -14.6%
Compare:IDT vs REGIDT vs CANIDT vs BIT
Scout Pro — Deeper Analysis for IDT
Try Pro free for 30 days
Share this analysis

Track IDT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required